Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

STAIR SLOS Longitudinal Study of Patients Receiving Cholesterol

Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction

Alexey M. Petrov, M. R. Kasimov, A. L. Zefirov. (2016). Acta Naturae. Cited 173 times. https://doi.org/10.32607/20758251-2016-8-1-58-73

DHCR7: A vital enzyme switch between cholesterol and vitamin D production.

Anika V. Prabhu, Winnie Luu, Dianfan Li, et al. (2016). Progress in lipid research. Cited 144 times. https://doi.org/10.1016/j.plipres.2016.09.003

Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update

A. Thurm, E. Tierney, C. Farmer, et al. (2016). Journal of Neurodevelopmental Disorders. Cited 58 times. https://doi.org/10.1186/s11689-016-9145-x

Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols

Navdar Sever, R. K. Mann, Libin Xu, et al. (2016). Proceedings of the National Academy of Sciences. Cited 55 times. https://doi.org/10.1073/pnas.1604984113

Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review

M. Boland, N. Tatonetti. (2016). The Pharmacogenomics Journal. Cited 54 times. https://doi.org/10.1038/tpj.2016.48

Cholesterolomics: An update

W. Griffiths, Jonas Abdel-Khalik, Eylan Yutuc, et al. (2017). Analytical Biochemistry. Cited 47 times. https://doi.org/10.1016/j.ab.2017.01.009

Inhibitors of 7-Dehydrocholesterol Reductase: Screening of a Collection of Pharmacologically Active Compounds in Neuro2a Cells.

Hye-Young H. Kim, Ž. Korade, K. Tallman, et al. (2016). Chemical research in toxicology. Cited 44 times. https://doi.org/10.1021/acs.chemrestox.6b00054

Modeling Smith-Lemli-Opitz syndrome with iPS cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes

K. Francis, A. Ton, Y. Xin, et al. (2016). Nature medicine. Cited 43 times. https://doi.org/10.1038/nm.4067

Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients

W. Griffiths, Jonas Abdel-Khalik, P. Crick, et al. (2017). The Journal of Steroid Biochemistry and Molecular Biology. Cited 42 times. https://doi.org/10.1016/j.jsbmb.2016.03.018

A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome

C. Wassif, L. Kratz, S. Sparks, et al. (2016). Genetics in medicine : official journal of the American College of Medical Genetics. Cited 39 times. https://doi.org/10.1038/gim.2016.102

Phosphorylation regulates activity of 7-dehydrocholesterol reductase (DHCR7), a terminal enzyme of cholesterol synthesis

Anika V. Prabhu, Winnie Luu, Laura J. Sharpe, et al. (2017). The Journal of Steroid Biochemistry and Molecular Biology. Cited 30 times. https://doi.org/10.1016/j.jsbmb.2016.08.003

Antenatal manifestations of inborn errors of metabolism: biological diagnosis

C. Vianey-Saban, C. Acquaviva, D. Cheillan, et al. (2016). Journal of Inherited Metabolic Disease. Cited 27 times. https://doi.org/10.1007/s10545-016-9947-8

7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome

Andras Balajthy, S. Somodi, Zoltan Pethő, et al. (2016). Pflügers Archiv - European Journal of Physiology. Cited 13 times. https://doi.org/10.1007/s00424-016-1851-4

7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome

M. Gou-Fàbregas, A. Macià, C. Anerillas, et al. (2016). Scientific Reports. Cited 7 times. https://doi.org/10.1038/srep28534

A Pilot Study of the Association of Markers of Cholesterol Synthesis with Disturbed Sleep in Smith-Lemli-Opitz Syndrome

K. A. Freeman, Erin L. Olufs, Megan E. Tudor, et al. (2016). Journal of Developmental & Behavioral Pediatrics. Cited 6 times. https://doi.org/10.1097/DBP.0000000000000317

Intracranial undifferentiated malign neuroglial tumor in Smith-Lemli-Opitz syndrome: A theory of a possible predisposing factor for primary brain tumors via a case report

A. Aslan, A. Borcek, Selma Pamukcuoglu, et al. (2016). Child's Nervous System. Cited 5 times. https://doi.org/10.1007/s00381-016-3214-z

The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome

A. Tucci, L. Ronzoni, C. Arduino, et al. (2016). BMC Medical Genetics. Cited 5 times. https://doi.org/10.1186/s12881-016-0287-1

Altered cerebrospinal fluid proteins in Smith–Lemli–Opitz syndrome patients

Stephanie M. Cologna, C. Shieh, Cynthia L. Toth, et al. (2016). American Journal of Medical Genetics Part A. Cited 4 times. https://doi.org/10.1002/ajmg.a.37720

Smith-Lemli-Opitz Syndrome- a challenging prenatal diagnosis.

Agata Szpera-Goździewicz, M. Ropacka-Lesiak, P. Rzymski, et al. (2016). Ginekologia polska. Cited 3 times. https://doi.org/10.17772/gp/61327

Patient iPSCs: a new discovery tool for Smith-Lemli-Opitz syndrome

Z. Wen, Hongjun Song, G. Ming. (2016). Nature Medicine. Cited 1 times. https://doi.org/10.1038/nm.4081